NM_032447.5:c.6031+141G>A

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_032447.5(FBN3):c.6031+141G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0152 (AC=17,471) in the gnomAD database across 1,149,846 control chromosomes, including 1,446 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.198. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.059 ( 869 hom., cov: 32)
Exomes 𝑓: 0.0084 ( 577 hom. )

Consequence

FBN3
NM_032447.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0580

Publications

1 publications found
Variant links:
Genes affected
FBN3 (HGNC:18794): (fibrillin 3) This gene encodes a memebr of the fibrillin protein family. Fibrillins are extracellular matrix molecules that assemble into microfibrils in many connective tissues. This gene is most highly expressed in fetal tissues and its protein product is localized to extracellular microfibrils of developing skeletal elements, skin, lung, kidney, and skeletal muscle. This gene is potentially involved in Weill-Marchesani syndrome. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_032447.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.1979 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_032447.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

FBN3 NM_032447.5
MANE Select
HGVSc / HGVSpc.6031+141G>A
Exon rankIntron 48 of 63
intron
Prot: NP_115823.3
FBN3 NM_001321431.2
HGVSc / HGVSpc.6031+141G>A
Exon rankIntron 48 of 63
intron
Prot: NP_001308360.1UniProt: Q75N90

Ensembl Transcripts

FBN3 ENST00000600128.6
TSL:1MANE Select
HGVSc / HGVSpc.6031+141G>A
Exon rankIntron 48 of 63
intron
Prot: ENSP00000470498.1UniProt: Q75N90
FBN3 ENST00000270509.6
TSL:1
HGVSc / HGVSpc.6031+141G>A
Exon rankIntron 47 of 62
intron
Prot: ENSP00000270509.2UniProt: Q75N90
FBN3 ENST00000601739.5
TSL:1
HGVSc / HGVSpc.6031+141G>A
Exon rankIntron 48 of 63
intron
Prot: ENSP00000472324.1UniProt: Q75N90

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.0593
AC:9025
Hom:864
AN:152138
Cov:32
GnomAD4 exome
AF: 0.00844
AC:8415
Hom:577
AN:997590
GnomAD4 genome
AF: 0.0595
AC:9056
Hom:869
AN:152256
Cov:32
TOPMed (Bravo)
AF: 0.0674
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0529
AC:1440
Hom:149
AN:27230
Local & regional cohorts 9 sources
ABraOM SABE-WGS-1171
AF: 0.0500
AC:117
Hom:7
AN:2342
ChinaMAP Phase 1
AF: 0.0249
GenomeAsia100K
AF: 0.0350
AC:123
AN:3478
Korea4K (4,157 Koreans)
AF: 0.00885
AC:64
AN:7234
Qatari Genome
AF: 0.0341
AC:6
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0180
AC:2214
Hom:25
AN:122690
Turkish Variome
AF: 0.00130
AC:2
Hom:0
AN:1544
UK10K
AF: 0.000529
AC:4
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.0269
AC:241
Hom:5
AN:8960
Showing 14 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.00330 21665496 0.00236 280118804
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign2.1
BayesDel_noAF
Benign-0.90
CADD
Benign5.1
DANN
Benign0.39
GPN-Star LLR
N/A0.46
GPN-Star score
N/A-0.46
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign0.058
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.